sunitinib remedica 25mg hard capsules
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents
sunitinib remedica 37.5mg hard capsules
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents
sunitinib remedica 50mg hard capsules
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastic agents - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance.metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults.pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
insunitinib capsule 12.5mg
intega pte ltd - sunitinib - capsule, gelatin coated - sunitinib 12.50 mg
insunitinib capsule 25mg
intega pte ltd - sunitinib - capsule, gelatin coated - sunitinib 25.00 mg
insunitinib capsule 37.5mg
intega pte ltd - sunitinib - capsule, gelatin coated - sunitinib 37.50 mg
insunitinib capsule 50mg
intega pte ltd - sunitinib - capsule, gelatin coated - sunitinib 50.00 mg
sunitinib eg 12.5 mg hard caps.
eg sa-nv - sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib 12.5 mg - sunitinib
sunitinib eg 25 mg hard caps.
eg sa-nv - sunitinib 25 mg - capsule, hard - 25 mg - sunitinib 25 mg - sunitinib